NDA Reports Sale of Controlled Drug to Users
The National Drug Agency (NDA) has reported receiving information that the controlled drug Buprenorphine is being sold to drug users in the Maldives.
According to details shared by NDA chairperson Lubna Zahir, the substance is allegedly being sold at a rate of MVR 2,000 for 10 tablets. She noted that multiple drug users have provided reliable information about those involved in the distribution.
advertisement
advertisement
advertisement
We have received information that Buprenorphine a controlled drug is been sold to drug users.
10 tablets are been sold for MVR 2000.00 . Selling controlled drugs is violation of Drug Law . There are many users who gave accurate information regarding sellers @PoliceMv @CustomsMv— Lubna (@LubnaZahir) September 19, 2025
Lubna highlighted that the sale of such controlled substances is a violation of the Drug Act.
Buprenorphine is a powerful opioid prescribed for the treatment of moderate to severe pain and is more commonly used in managing opioid use disorder, including addiction to heroin or morphine. It acts as a partial agonist-antagonist at opioid receptors, reducing withdrawal symptoms and cravings, while lowering the risk of misuse as it does not produce the full euphoric effects associated with other opioids.
